» Articles » PMID: 10736260

Roles of Molecular Chaperones in Cytoplasmic Protein Folding

Overview
Date 2000 Mar 29
PMID 10736260
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Newly synthesized polypeptide chains must fold and assemble into unique three-dimensional structures in order to become functionally active. In many cases productive folding depends on assistance from molecular chaperones, which act in preventing off-pathway reactions during folding that lead to aggregation. The inherent tendency of incompletely folded polypeptide chains to aggregate is thought to be strongly enhanced$L in vivo *I$Lby the high macromolecular concentration of the cellular solution, resulting in crowding effects, and by the close proximity of nascent polypeptide chains during synthesis on polyribosomes. The major classes of chaperones acting in cytoplasmic protein folding are the Hsp70s and the chaperonins. Hsp70 chaperones shield the hydrophobic regions of nascent and incompletely folded chains, whereas the chaperonins provide a sequestered environment in which folding can proceed unimpaired by intermolecular interactions between non-native polypeptides. These two principles of chaperone action can function in a coordinated manner to ensure the efficient folding of a subset of cytoplasmic proteins.

Citing Articles

Combined strategies for improving the heterologous expression of a novel xylanase from Fo47 in .

Liu C, Zhang Y, Ye C, Zhao F, Chen Y, Han S Synth Syst Biotechnol. 2024; 9(3):426-435.

PMID: 38601209 PMC: 11004072. DOI: 10.1016/j.synbio.2024.03.012.


Exploration of the truncated cytosolic Hsp70 in plants - unveiling the diverse T1 lineage and the conserved T2 lineage.

Chen Y, Cheng S, Liu C, Tsai W, Wu H, Huang M Front Plant Sci. 2023; 14:1279540.

PMID: 38034583 PMC: 10687569. DOI: 10.3389/fpls.2023.1279540.


Protein Misfolding and Aggregation in Proteinopathies: Causes, Mechanism and Cellular Response.

Ajmal M Diseases. 2023; 11(1).

PMID: 36810544 PMC: 9944956. DOI: 10.3390/diseases11010030.


The therapeutic potential of triptolide and celastrol in neurological diseases.

Cui Y, Jiang X, Feng J Front Pharmacol. 2022; 13:1024955.

PMID: 36339550 PMC: 9626530. DOI: 10.3389/fphar.2022.1024955.


Proteinopathies: Deciphering Physiology and Mechanisms to Develop Effective Therapies for Neurodegenerative Diseases.

Chopra G, Shabir S, Yousuf S, Kauts S, Bhat S, Mir A Mol Neurobiol. 2022; 59(12):7513-7540.

PMID: 36205914 DOI: 10.1007/s12035-022-03042-8.